Stocks · News reference
Trinity Biotech Enters Collaboration With Intradermal Drug Delivery Platform Maker Latch Medical
The collaboration is intended to combine data streams from Trinity Biotech's CGM+ wearable biosensor platform with Latch Medical's advanced drug delivery technologies to evaluate the development of precision
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 22, 2026, 11:35 AM
- Checked
- Jul 22, 2026, 11:35 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Trinity Biotech Receives ~$7M Of Additional Investment From Funds Managed By Perceptive Advisors; Regains Compliance With Nasdaq Minimum Bid Price Requirement
The Company also announced that it has regained compliance with Nasdaq’s minimum bid price requirement, marking another positive development as Trinity Biotech continues to execute its strategic priorities.Perceptive
Read original at benzingaTrading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Read original at benzingaTrinity Biotech shares are trading lower after the company announced a ADS ratio change that has the same effect of a 1-for-30 reverse ADS split.
Read original at benzinga